{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:33:37Z","timestamp":1792791217640,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Scientific Research Projects Branch Directorate of Ege University, T\u00fcrkiye","award":["22890"],"award-info":[{"award-number":["22890"]}],"id":[{"id":"https:\/\/ror.org\/02eaafc18","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-14988-9","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:49:59Z","timestamp":1758883799000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Recombinant ROP6 protein expressed in Saccharomyces cerevisiae INVSc1 cells induced strong immune response and provided significant protection against toxoplasmosis"],"prefix":"10.1038","volume":"15","author":[{"given":"Tu\u011fba","family":"Karakavuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammet","family":"Karakavuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceren","family":"G\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fcseyin","family":"Can","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayt\u00fcl","family":"G\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedef Erkunt","family":"Alak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysu De\u011firmenci","family":"D\u00f6\u015fkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seren","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130rem","family":"Yavuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Akbaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcl\u015fah Erel","family":"Akbaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didem \u015een","family":"Karaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Efe","family":"K\u00f6seo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tolga","family":"Ovayurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan Y\u00fcksel","family":"G\u00fcr\u00fcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cemal","family":"\u00dcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe G\u00fclten","family":"Kantarc\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mert","family":"D\u00f6\u015fkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"14988_CR1","doi-asserted-by":"publisher","unstructured":"Attias, M. et al. The life-cycle of Toxoplasma gondii reviewed using animations. Parasites and Vectors vol. 13 Preprint at (2020). https:\/\/doi.org\/10.1186\/s13071-020-04445-z","DOI":"10.1186\/s13071-020-04445-z"},{"key":"14988_CR2","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1080\/21505594.2021.2012346","volume":"12","author":"SG Sanchez","year":"2021","unstructured":"Sanchez, S. G. & Besteiro, S. The pathogenicity and virulence of Toxoplasma gondii. Virulence 12, 3095\u20133114 (2021).","journal-title":"Virulence"},{"key":"14988_CR3","doi-asserted-by":"publisher","unstructured":"Matta, S. K., Rinkenberger, N., Dunay, I. R. & Sibley, L. D. Toxoplasma gondii infection and its implications within the central nervous system. Nature Reviews Microbiology vol. 19 467\u2013480 Preprint at (2021). https:\/\/doi.org\/10.1038\/s41579-021-00518-7","DOI":"10.1038\/s41579-021-00518-7"},{"key":"14988_CR4","doi-asserted-by":"crossref","unstructured":"Barrios, L. C. et al. Behavioral alterations in long-term Toxoplasma gondii infection of C57BL\/6 mice are associated with neuroinflammation and disruption of the blood brain barrier. PLoS One 16, e0258199 (2021).","DOI":"10.1371\/journal.pone.0258199"},{"key":"14988_CR5","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1046\/j.1469-0691.2002.00485.x","volume":"8","author":"D Hill","year":"2002","unstructured":"Hill, D. & Dubey, J. Toxoplasma gondii: transmission, diagnosis and prevention. Clin. Microbiol. Infect. 8, 634\u2013640 (2002).","journal-title":"Clin. Microbiol. Infect."},{"key":"14988_CR6","doi-asserted-by":"crossref","unstructured":"Karakavuk, M. et al. GRA8 DNA vaccine formulations protect against chronic toxoplasmosis. Microb Pathog 158, 105016 (2021).","DOI":"10.1016\/j.micpath.2021.105016"},{"key":"14988_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1297-9716-42-121","volume":"42","author":"F Katzer","year":"2011","unstructured":"Katzer, F. et al. Increased Toxoplasma gondii positivity relative to age in 125 Scottish sheep flocks; evidence of frequent acquired infection. Vet. Res. 42, 1\u20139 (2011).","journal-title":"Vet. Res."},{"key":"14988_CR8","doi-asserted-by":"crossref","unstructured":"Stelzer, S. et al. Toxoplasma gondii infection and toxoplasmosis in farm animals: risk factors and economic impact. Food Waterborne Parasitol 15, e00037 (2019).","DOI":"10.1016\/j.fawpar.2019.e00037"},{"key":"14988_CR9","first-page":"1","volume":"8","author":"M Pan","year":"2017","unstructured":"Pan, M., Lyu, C., Zhao, J., Shen, B. & Sixty Years 1957\u20132017) of research on toxoplasmosis in China-An overview. Front. Microbiol. 8, 1\u201316 (2017).","journal-title":"Front. Microbiol."},{"key":"14988_CR10","doi-asserted-by":"publisher","unstructured":"Montazeri, M. et al. Drug resistance in toxoplasma gondii. Frontiers in Microbiology vol. 9 Preprint at (2018). https:\/\/doi.org\/10.3389\/fmicb.2018.02587","DOI":"10.3389\/fmicb.2018.02587"},{"key":"14988_CR11","unstructured":"Andersson, C. Production and Delivery of Recombinant Subunit Vaccines (Royal Institute of Technology (KTH), 2000)."},{"key":"14988_CR12","doi-asserted-by":"publisher","unstructured":"Karakavuk, T. et al. Biotechnological Based Recombinant Protein Vaccines Developed Against Toxoplasmosis. Turkiye Parazitoloji Dergisi vol. 46 342\u2013357 Preprint at (2022). https:\/\/doi.org\/10.4274\/tpd.galenos.2022.41636","DOI":"10.4274\/tpd.galenos.2022.41636"},{"key":"14988_CR13","doi-asserted-by":"publisher","unstructured":"G\u00fcl, C. et al. Toxoplasma gondii\u2019ye Kar\u015f\u0131 Geli\u015ftirilen DNA A\u015f\u0131lar\u0131na Genel Bir Bak\u0131\u015f. Turkiye parazitolojii dergisi vol. 46 253\u2013270 Preprint at (2022). https:\/\/doi.org\/10.4274\/tpd.galenos.2022.02486","DOI":"10.4274\/tpd.galenos.2022.02486"},{"key":"14988_CR14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/jphp.12353","volume":"67","author":"RM Bill","year":"2015","unstructured":"Bill, R. M. Recombinant protein subunit vaccine synthesis in microbes: A role for yeast? J. Pharm. Pharmacol. 67, 319\u2013328 (2015).","journal-title":"J. Pharm. Pharmacol."},{"key":"14988_CR15","unstructured":"Orenstein, W., Offit, P., Edwards, K. & Plotkin, S. S. Plotkin\u2019s Vaccines 7th Edn (Elsevier, 2017)."},{"key":"14988_CR16","doi-asserted-by":"publisher","unstructured":"Zhang, N. Z., Wang, M., Xu, Y., Petersen, E. & Zhu, X. Q. Recent advances in developing vaccines against Toxoplasma gondii: An update. Expert Review of Vaccines vol. 14 1609\u20131621 Preprint at (2015). https:\/\/doi.org\/10.1586\/14760584.2015.1098539","DOI":"10.1586\/14760584.2015.1098539"},{"key":"14988_CR17","doi-asserted-by":"publisher","unstructured":"Gupta, S. & Pellett, S. Recent Developments in Vaccine Design: From Live Vaccines to Recombinant Toxin Vaccines. Toxins vol. 15 Preprint at (2023). https:\/\/doi.org\/10.3390\/toxins15090563","DOI":"10.3390\/toxins15090563"},{"key":"14988_CR18","doi-asserted-by":"publisher","unstructured":"Venugopal, K. & Marion, S. Secretory organelle trafficking in Toxoplasma gondii: A long story for a short travel. International Journal of Medical Microbiology vol. 308 751\u2013760 Preprint at (2018). https:\/\/doi.org\/10.1016\/j.ijmm.2018.07.007","DOI":"10.1016\/j.ijmm.2018.07.007"},{"key":"14988_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.7774\/cevr.2019.8.1.4","volume":"8","author":"M Foroutan","year":"2019","unstructured":"Foroutan, M., Ghaffarifar, F., Sharifi, Z., Dalimi, A. & Jorjani, O. Rhoptry antigens as Toxoplasma gondii vaccine target. Clin. Exp. Vaccine Res. 8, 4\u201326 (2019).","journal-title":"Clin. Exp. Vaccine Res."},{"key":"14988_CR20","doi-asserted-by":"publisher","unstructured":"Rezaei, F. et al. A systematic review of Toxoplasma gondii antigens to find the best vaccine candidates for immunization. Microbial Pathogenesis vol. 126 172\u2013184 Preprint at (2019). https:\/\/doi.org\/10.1016\/j.micpath.2018.11.003","DOI":"10.1016\/j.micpath.2018.11.003"},{"key":"14988_CR21","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1017\/S0031182014001978","volume":"142","author":"J Felgner","year":"2015","unstructured":"Felgner, J. et al. Identification of Toxoplasma gondii antigens associated with different types of infection by serum antibody profiling. Parasitology 142, 827\u2013838 (2015).","journal-title":"Parasitology"},{"key":"14988_CR22","doi-asserted-by":"crossref","unstructured":"D\u00f6\u015fkaya, M. et al. Discovery of new Toxoplasma gondii antigenic proteins using a high throughput protein microarray approach screening Sera of murine model infected orally with oocysts and tissue cysts. Parasit Vectors 11, 17(1), 243 (2018).","DOI":"10.1186\/s13071-018-2934-1"},{"key":"14988_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1074\/mcp.M110.006916","volume":"10","author":"L Liang","year":"2011","unstructured":"Liang, L. et al. Identification of potential serodiagnostic and subunit vaccine antigens by antibody profiling of toxoplasmosis cases in Turkey. Mol. Cell. Proteomics. 10, 1\u201317 (2011).","journal-title":"Mol. Cell. Proteomics"},{"key":"14988_CR24","doi-asserted-by":"crossref","unstructured":"Fritz, H. M., Bowyer, P. W., Bogyo, M., Conrad, P. A. & Boothroyd, J. C. Proteomic analysis of fractionated Toxoplasma oocysts reveals clues to their environmental resistance. PLoS One 7, e29955 (2012).","DOI":"10.1371\/journal.pone.0029955"},{"key":"14988_CR25","doi-asserted-by":"crossref","unstructured":"Fritz, H. M. et al. Transcriptomic analysis of Toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. PLoS One 7, e29998 (2012).","DOI":"10.1371\/journal.pone.0029998"},{"key":"14988_CR26","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1021\/bp0201105","volume":"18","author":"AE Raj","year":"2002","unstructured":"Raj, A. E. et al. High-cell-density fermentation of Recombinant Saccharomyces cerevisiae using glycerol. Biotechnol. Prog. 18, 1130\u20131132 (2002).","journal-title":"Biotechnol. Prog"},{"key":"14988_CR27","doi-asserted-by":"publisher","unstructured":"Baghban, R. et al. Yeast Expression Systems: Overview and Recent Advances. Molecular Biotechnology vol. 61 365\u2013384 Preprint at (2019). https:\/\/doi.org\/10.1007\/s12033-019-00164-8","DOI":"10.1007\/s12033-019-00164-8"},{"key":"14988_CR28","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.pep.2014.06.011","volume":"101","author":"WK Lee","year":"2014","unstructured":"Lee, W. K., Ahn, H. J., Yu, Y. G. & Nam, H. W. Rhoptry protein 6 from Toxoplasma gondii is an intrinsically disordered protein. Protein Expr Purif. 101, 146\u2013151 (2014).","journal-title":"Protein Expr Purif."},{"key":"14988_CR29","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1021\/pr2002325","volume":"10","author":"K Helsens","year":"2011","unstructured":"Helsens, K. et al. Bioinformatics analysis of a Saccharomyces cerevisiae N-terminal proteome provides evidence of alternative translation initiation and post-translational N-terminal acetylation. J. Proteome Res. 10, 3578\u20133589 (2011).","journal-title":"J. Proteome Res."},{"key":"14988_CR30","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/pro.2860","volume":"25","author":"SV Kathuria","year":"2016","unstructured":"Kathuria, S. V., Chan, Y. H., Nobrega, R. P., \u00d6zen, A. & Matthews, C. R. Clusters of isoleucine, leucine, and valine side chains define cores of stability in high-energy States of globular proteins: sequence determinants of structure and stability. Protein Sci. 25, 662\u2013675 (2016).","journal-title":"Protein Sci."},{"key":"14988_CR31","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1017\/S003118200000144X","volume":"110","author":"D Buxton","year":"1995","unstructured":"Buxton, D. & Innes, E. A. A commercial vaccine for ovine toxoplasmosis. Parasitology 110, S11\u2013S16 (1995).","journal-title":"Parasitology"},{"key":"14988_CR32","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S1286-4579(03)00048-0","volume":"5","author":"GM Bhopale","year":"2003","unstructured":"Bhopale, G. M. Development of a vaccine for toxoplasmosis: current status. Microbes Infect. 5, 457\u2013462 (2003).","journal-title":"Microbes Infect."},{"key":"14988_CR33","doi-asserted-by":"crossref","unstructured":"Liljeqvist, S. & St\u00e5hl, S. Production of Recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines. Journal Biotechnology 73, 1\u201333 (1999). www.elsevier.com\/locate\/jbiotec","DOI":"10.1016\/S0168-1656(99)00107-8"},{"key":"14988_CR34","doi-asserted-by":"publisher","unstructured":"Hudu, S. A., Shinkafi, S. H. & Umar, S. An overview of recombinant vaccine technology, adjuvants and vaccine delivery methods. International Journal of Pharmacy and Pharmaceutical Sciences vol. 8 19\u201324 Preprint at (2016). https:\/\/doi.org\/10.22159\/ijpps.2016v8i11.14311","DOI":"10.22159\/ijpps.2016v8i11.14311"},{"key":"14988_CR35","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1016\/j.vaccine.2018.05.072","volume":"36","author":"L Wang","year":"2018","unstructured":"Wang, L. et al. Protective immune response against Toxoplasma gondii elicited by a novel yeast-based vaccine with microneme protein 16. Vaccine 36, 3943\u20133948 (2018).","journal-title":"Vaccine"},{"key":"14988_CR36","doi-asserted-by":"publisher","unstructured":"Zhao, M., Ma, J., Zhang, L. & Qi, H. Engineering strategies for enhanced heterologous protein production by Saccharomyces cerevisiae. Microbial Cell Factories vol. 23 Preprint at (2024). https:\/\/doi.org\/10.1186\/s12934-024-02299-z","DOI":"10.1186\/s12934-024-02299-z"},{"key":"14988_CR37","doi-asserted-by":"crossref","unstructured":"Erkunt Alak, S. et al. An optimized ROP6 mRNA construct successfully expressed Immunogenic Toxoplasma gondii ROP6 protein in cell culture. Gene 935, 149073 (2025).","DOI":"10.1016\/j.gene.2024.149073"},{"key":"14988_CR38","doi-asserted-by":"publisher","unstructured":"Ojha, R. & Prajapati, V. K. Cognizance of posttranslational modifications in vaccines: A way to enhanced immunogenicity. Journal of Cellular Physiology vol. 236 8020\u20138034 Preprint at (2021). https:\/\/doi.org\/10.1002\/jcp.30483","DOI":"10.1002\/jcp.30483"},{"key":"14988_CR39","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1128\/cvi.00195-13","volume":"20","author":"H Seitz","year":"2013","unstructured":"Seitz, H., Dantheny, T., Burkart, F., Ottonello, S. & M\u00fcller, M. Influence of oxidation and multimerization on the immunogenicity of a thioredoxin-L2 prophylactic papillomavirus vaccine. Clin. Vaccine Immunol. 20, 1061\u20131069 (2013).","journal-title":"Clin. Vaccine Immunol."},{"key":"14988_CR40","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0022-2836(03)00182-7","volume":"327","author":"K Mel\u00e9n","year":"2003","unstructured":"Mel\u00e9n, K., Krogh, A. & Von Heijne, G. Reliability measures for membrane protein topology prediction algorithms. J. Mol. Biol. 327, 735\u2013744 (2003).","journal-title":"J. Mol. Biol."},{"key":"14988_CR41","doi-asserted-by":"crossref","unstructured":"Doytchinova, I. A., & Flower, D. R. VaxiJen A server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics 8, 4 (2007).","DOI":"10.1186\/1471-2105-8-4"},{"key":"14988_CR42","doi-asserted-by":"crossref","unstructured":"Saha, S. & Raghava, G. P. S.  AlgPred Prediction of allergenic proteins and mapping of IgE epitopes. Nucleic Acids Res 34, 202\u2013209 (2006).","DOI":"10.1093\/nar\/gkl343"},{"key":"14988_CR43","doi-asserted-by":"crossref","unstructured":"Cheng, J., Randall, A. Z., Sweredoski, M. J. & Baldi, P. SCRATCH: A protein structure and structural feature prediction server. Nucleic Acids Res 33, (2005).","DOI":"10.1093\/nar\/gki396"},{"key":"14988_CR44","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1093\/bioinformatics\/btp386","volume":"25","author":"CN Magnan","year":"2009","unstructured":"Magnan, C. N., Randall, A., Baldi, P. & SOLpro Accurate sequence-based prediction of protein solubility. Bioinformatics 25, 2200\u20132207 (2009).","journal-title":"Bioinformatics"},{"key":"14988_CR45","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1093\/nar\/gkg563","volume":"31","author":"E Gasteiger","year":"2003","unstructured":"Gasteiger, E. et al. ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res. 31, 3784\u20133788 (2003).","journal-title":"Nucleic Acids Res."},{"key":"14988_CR46","doi-asserted-by":"crossref","unstructured":"Yao, B., Zhang, L., Liang, S. & Zhang, C. SVMTriP: A method to predict antigenic epitopes using support vector machine to integrate Tri-Peptide similarity and propensity. PLoS One 7, e45152 (2012).","DOI":"10.1371\/journal.pone.0045152"},{"key":"14988_CR47","doi-asserted-by":"publisher","unstructured":"Jiang, L. et al. Predicting MHC class I binder: existing approaches and a novel recurrent neural network solution. Briefings in Bioinformatics vol. 22 Preprint at (2021). https:\/\/doi.org\/10.1093\/bib\/bbab216","DOI":"10.1093\/bib\/bbab216"},{"key":"14988_CR48","doi-asserted-by":"crossref","unstructured":"Can, H., Alak, E., K\u00f6seo\u011flu, S., D\u00f6\u015fkaya, A. E. & \u00dcn, C. M. Do Toxoplasma gondii apicoplast proteins have antigenic potential? An in silico study. Comput Biol. Chem 84, 107158 (2020).","DOI":"10.1016\/j.compbiolchem.2019.107158"},{"key":"14988_CR49","doi-asserted-by":"crossref","unstructured":"Hansen, J. E. et al. NetOglyc: Prediction of Mucin Type O-Glycosylation Sites Based on Sequence Context and Surface Accessibility. Glycoconjugate Journal vol. 15 (1998). http:\/\/www.cbs.dtu.dk\/services\/NetOGlyc\/","DOI":"10.1023\/A:1006960004440"},{"key":"14988_CR50","doi-asserted-by":"crossref","unstructured":"Li, J., Liang, Q., Song, W. & Marchisio, M. A. Nucleotides upstream of the Kozak sequence strongly influence gene expression in the yeast S. cerevisiae. J Biol. Eng 11, 25 (2017).","DOI":"10.1186\/s13036-017-0068-1"},{"key":"14988_CR51","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.vaccine.2006.10.060","volume":"25","author":"M D\u00f6\u015fkaya","year":"2007","unstructured":"D\u00f6\u015fkaya, M. et al. GRA1 protein vaccine confers better immune response compared to codon-optimized GRA1 DNA vaccine. Vaccine 25, 1824\u20131837 (2007).","journal-title":"Vaccine"},{"key":"14988_CR52","doi-asserted-by":"crossref","unstructured":"Parmaks\u0131z, S. et al. Development of multistage Recombinant protein vaccine formulations against toxoplasmosis using a new Chitosan and Porin based adjuvant system. Int J. Pharm 626, 122199 (2022).","DOI":"10.1016\/j.ijpharm.2022.122199"},{"key":"14988_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.06.032","author":"C G\u00fcl","year":"2024","unstructured":"G\u00fcl, C. et al. A novel DNA vaccine encoding the SRS13 protein administered by electroporation confers protection against chronic toxoplasmosis. Vaccine https:\/\/doi.org\/10.1016\/j.vaccine.2024.06.032 (2024).","journal-title":"Vaccine"},{"key":"14988_CR54","doi-asserted-by":"crossref","unstructured":"D\u00f6\u015fkaya, M. et al. Diagnostic value of a Rec-ELISA using Toxoplasma gondii Recombinant sporosag, BAG1, and GRA1 proteins in murine models infected orally with tissue cysts and oocysts. PLoS One 9, e108329 (2014).","DOI":"10.1371\/journal.pone.0108329"},{"key":"14988_CR55","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.trivac.2015.11.002","volume":"5","author":"Y Gedik","year":"2016","unstructured":"Gedik, Y. et al. Immunogenic multistage Recombinant protein vaccine confers partial protection against experimental toxoplasmosis mimicking natural infection in murine model. Trials Vaccinol. 5, 15\u201323 (2016).","journal-title":"Trials Vaccinol."},{"key":"14988_CR56","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1016\/j.vaccine.2022.03.014","volume":"40","author":"A G\u00fcl","year":"2022","unstructured":"G\u00fcl, A. et al. Immunogenicity of a xenogeneic multi-epitope HER2\u2009+\u2009breast cancer DNA vaccine targeting the dendritic cell restricted antigen-uptake receptor DEC205. Vaccine 40, 2409\u20132419 (2022).","journal-title":"Vaccine"},{"key":"14988_CR57","doi-asserted-by":"crossref","unstructured":"Karakavuk, M. et al. Genetic characterization of Toxoplasma gondii strains isolated from humans living in \u0130zmir, T\u00fcrkiye. Indian J. Med. Microbiol 49, 100571 (2024).","DOI":"10.1016\/j.ijmmb.2024.100571"},{"key":"14988_CR58","doi-asserted-by":"crossref","unstructured":"D\u00f6\u015fkaya, M. et al. Comparison of an in house and a commercial real-time polymerase chain reaction targeting Toxoplasma gondii RE gene using various samples collected from patients in Turkey. BMC Infect. Dis 19, 1042 (2019).","DOI":"10.1186\/s12879-019-4666-z"},{"key":"14988_CR59","doi-asserted-by":"crossref","unstructured":"Karakavuk, M. et al. Prevalence of toxoplasmosis and genetic characterization of Toxoplasma gondii strains isolated in wild birds of prey and their relation with previously isolated strains from Turkey. PLoS One 13, e0196159 (2018).","DOI":"10.1371\/journal.pone.0196159"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14988-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14988-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14988-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:50:16Z","timestamp":1758883816000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14988-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14988"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-14988-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"19 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32979"}}